KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Non-Current Debt (2020 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Non-Current Debt for 7 consecutive years, with $2.0 billion as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Debt changed 0.07% year-over-year to $2.0 billion; the TTM value through Mar 2026 reached $2.0 billion, changed 0.07%, while the annual FY2025 figure was $2.0 billion, 0.08% changed from the prior year.
  • Non-Current Debt hit $2.0 billion in Q1 2026 for Regeneron Pharmaceuticals, roughly flat from $2.0 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $2.0 billion in Q1 2026 and bottomed at $2.0 billion in Q1 2022.
  • Average Non-Current Debt over 5 years is $2.0 billion, with a median of $2.0 billion recorded in 2024.
  • Year-over-year, Non-Current Debt increased 0.08% in 2025 and then rose 0.07% in 2026.
  • Regeneron Pharmaceuticals' Non-Current Debt stood at $2.0 billion in 2022, then grew by 0.08% to $2.0 billion in 2023, then increased by 0.08% to $2.0 billion in 2024, then grew by 0.08% to $2.0 billion in 2025, then increased by 0.01% to $2.0 billion in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $2.0 billion, $2.0 billion, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.